Oct 13, 2026 · 7 min
Bank revenue disappoints as UnitedHealth lifts outlook
JPMorgan and Wells Fargo Report; JNJ and UNH Earnings
The episode captures how investors are separating headline earnings beats from the revenue, growth and valuation signals shaping early earnings-season reactions.
- 1JPMorgan and Wells Fargo shares fall as revenue trends undershoot expectations despite resilient banking metrics.
- 2UnitedHealth raises its profit outlook and beats quarterly estimates as easing medical costs support its shares.
- 3Johnson & Johnson lifts guidance but declines as investors weigh slower device growth and valuation after a strong run.
Don't miss
UnitedHealth’s shares gain after the company raises its profit outlook and beats quarterly estimates as medical costs ease.
The brief
Early earnings season opens with JPMorgan and Wells Fargo under pressure: both show resilient banking metrics, but weaker-than-forecast revenue trends weigh on their shares.
Nathan Hager and Dan Curtis focus on the gap between operating details and market expectations, including JPMorgan’s softer revenue and fixed-income trading results.
UnitedHealth provides the clearest positive reaction, raising its full-year profit outlook and beating quarterly estimates as medical costs ease.
Johnson & Johnson also raises guidance and beats estimates, yet falls after a strong run as investors question medical-device growth and valuation.
The episode closes with a preview of Economy of Scale, examining how artificial intelligence and long-term planning could help cities manage rapid urbanization.
Books & mentions
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.